How strategic market access insights strengthen coverage and accelerate access

Real-world perspectives from payers, PBMs, SPs, and IDNs to inform smarter strategy

Today’s access environment is increasingly complex. Payer expectations are evolving rapidly, and conventional assumptions around coverage, evidence, and approval criteria are no longer sufficient. Success requires more than compelling clinical data; it demands targeted strategy grounded in real-world stakeholder insights.

Acumetis Strategic Global Value and Access Insights Service empowers pharmaceutical manufacturers with the clarity to navigate the evolving access environment with confidence. We deliver insight-driven guidance by integrating perspectives from payers, PBMs, SPs, IDN decision makers, translating stakeholder expectations into meaningful access strategies.

Our approach

Transforming stakeholder perspectives into strategic direction

We go beyond traditional market research to uncover what truly drives access decisions. Our methodology blends qualitative and quantitative research, secondary research, advanced analytics, and input from our proprietary Acumetis Advisor Network, a curated panel of 1,400+ vetted healthcare stakeholders.

This approach enables us to generate actionable insights that are both timely and strategically aligned. Whether preparing for launch, refining your value story, or adjusting to evolving payer dynamics, we provide the strategic foundation to move decisively.

What we deliver

Our global value and access insights service supports strategic decision points throughout the product lifecycle:

  • Stakeholder insights to inform coverage strategy, pricing, and positioning
  • Flexible support for research design, data collection, analysis, and custom reporting
  • Advisory engagements including Mock P&T panels, payer workshops, and Strategic Working Groups
  • Rapid Response Survey Tool (RRST) for fast-turn, targeted insight generation
  • Competitive intelligence and access benchmarking
  • Advanced analytics and modeling to support scenario planning

Why Acumetis

Expert-led. Insight-rich. Strategy-focused.
  • Supported 200+ launches across 20+ years
  • Multidisciplinary team with expertise in data science, behavioral strategy, and payer engagement
  • Long-term market access client relationships (average tenure ~7 years)
  • Access to 1,400+ vetted payers and decision-makers via the Acumetis Advisor Network
  • Flexible support models: full-service project execution or targeted insight generation
  • Moderated engagements led by experienced strategists

Global Acumetis advisor network

Through our Global Acumetis Advisor Network, we deliver access to the decision-makers shaping access strategy:

Health Plans

Engaging pharmacy, medical, and executive leaders across national, regional, and Blues plans—additionally, C-suite executives, quality directors and practice managers.

PBMs

Connecting with key pharmacy, contracting, and medical stakeholders at top U.S. pharmacy benefit managers.

IDNs

Reaching decision-makers across integrated delivery networks, including those with health plan components.

Global Decision Makers

Partnering with health economists, payer experts, academic experts, and former HTA leaders to shape global access strategy.

Acumetis global value & access team

Achieving global market access requires more than strong clinical data — it requires a value foundation that is strong enough to build on and flexible enough to adapt as markets evolve. We bring together integrated, multi-capability expertise to define where your asset demonstrates value, build the evidence that proves it, and communicate it in a way that achieves success and drives adoption. Built on 100+ economic models across 20+ countries, our consultants’ partner with you to de-risk the decisions that shape commercialization success for the widest patient population.

 

Let’s accelerate your access strategy

Whether preparing for launch, responding to shifting payer dynamics, or enhancing pull-through, Acumetis delivers strategic insight to unlock access and drive impact.

Request a Consultation

Our experts can help you reframe what’s possible. 

Let's Talk

"*" indicates required fields

Learn More

Meet the Experts:

James Convery
James Convery
Principal, Global Value and Access

James is a highly accomplished commercial strategist and value creation executive with over 20 years of client and full-service agency and consulting experience. He has been directly responsible for managing brands or servicing clients across a variety of healthcare verticals, including pharmaceuticals, specialty pharmaceuticals and hospital and institutional products. Areas of expertise include strategy development, brand and channel marketing, market access, patient support services and market research methodology. He has a proven record of success developing profitable HCP, payer and patient strategies and solutions.

FAQs on Acumetis advisor network

1. What is the Acumetis Advisor Network?

The Acumetis Advisor Network is a curated network of 1,400+ vetted healthcare stakeholders that provides strategic perspectives to help inform market access, payer, and commercialization decisions.

2. Who is included in the Acumetis Advisor Network?

The network includes payers, PBMs, specialty pharmacy stakeholders, IDN decision makers, health economists, academic experts, and former HTA leaders across global markets.

3. How does the Acumetis Advisor Network support access strategy?

The network helps organizations gather real-world perspectives on coverage expectations, evidence requirements, pricing considerations, and evolving market access dynamics.

4. How are insights from the Acumetis Advisor Network used?

Insights from the network support stakeholder research, advisory engagements, Mock P&T panels, payer workshops, strategic planning, and access-related decision making throughout the product lifecycle.